KLRC1 and neoplasm: Using multiplex immunohistochemistry (mIHC), we demonstrated that PD‐1+NKG2A+ NK cells co-localize with PD‐L1+/HLA‐E+ tumor regions, revealing a spatially organized immunosuppressive niche where inhibitory ligands and suppressed NK subsets are compartmentalized.